key: cord-0696392-bbk2z5e2
authors: J. Devoe, Daniel; Han, Angela; Anderson, Alida; Katzman, Debra K.; Patten, Scott B.; Soumbasis, Andrea; Flanagan, Jordyn; Paslakis, Georgios; Vyver, Ellie; Marcoux, Gisele; Dimitropoulos, Gina
title: The impact of the COVID‐19 pandemic on eating disorders: A systematic review
date: 2022-04-05
journal: Int J Eat Disord
DOI: 10.1002/eat.23704
sha: af1a59f10b8911eba94556a5021378692c60f292
doc_id: 696392
cord_uid: bbk2z5e2

OBJECTIVE: A growing body of evidence suggests that individuals with eating disorders (EDs) have experienced deteriorating symptoms, increased isolation, and an increase in hospital admissions as a result of the COVID‐19 pandemic. Despite this, no systematic reviews have been conducted examining the COVID‐19 and ED peer‐reviewed literature. Therefore, this systematic review aimed to synthesize the impact of the COVID‐19 pandemic on individuals with EDs. METHOD: Database searches of the peer‐reviewed literature were completed in the subsequent databases: CINAHL, Embase, MEDLINE, and PsycINFO (from November 2019 to October 20, 2021). All research reporting on the relationship between the COVID‐19 pandemic on individuals with EDs were included. RESULTS: Fifty‐three studies met the inclusion criteria, including 36,485 individuals with EDs. The pooled hospital admissions across the studies demonstrated on average a 48% (pre = 591, post = 876, n = 10 studies) increase in admissions during the pandemic compared to previous pre‐pandemic timepoints. In this review, 36% of studies (n = 19) documented increases in eating disorder symptoms during the pandemic, this increase in eating disorder symptoms were documented in AN, BED, BN, and OFSED patients. Studies also demonstrated increases in anxiety (n = 9) and depression (n = 8), however patterns of change appeared to be diagnostic and timing specific (e.g., lockdowns). DISCUSSION: We found a large increase in the number of hospitalizations and an increase in ED symptoms, anxiety, depression, and changes to BMI in ED patients during the pandemic. However, these changes appeared to be diagnostic and timing specific. Many qualitative studies described deterioration in ED symptomatology due to decreased access to care and treatment, changes to routine and loss of structure, negative influence of the media, and social isolation. Future studies are needed to focus on pediatric populations, new ED diagnoses, and severity of illness at presentation. PUBLIC SIGNIFICANCE: The scientific literature suggests that individuals with eating disorders have experienced deteriorating symptoms, increased isolation, and an increase in hospital admissions as a result of the COVID‐19 pandemic. This study synthesized 53 articles and explored the impact of the COVID‐19 pandemic on patients with eating disorders. We found increases in eating disorder symptoms during the pandemic; this increase in eating disorder symptoms was documented in patients with common eating disorders including anorexia nervosa, binge‐eating disorder, bulimia nervosa, and other specified feeding and eating disorders. This review also demonstrated changes in body mass index (an index used to classify underweight, overweight, and obesity in adults) and increases in anxiety and depression during the pandemic compared to previous timepoints; patterns of change appeared to be related to timing of lockdowns. This review provides important information on the impact of COVID‐19 on the physical and mental health of individuals with eating disorders.

this increase in eating disorder symptoms was documented in patients with common eating disorders including anorexia nervosa, binge-eating disorder, bulimia nervosa, and other specified feeding and eating disorders. This review also demonstrated changes in body mass index (an index used to classify underweight, overweight, and obesity in adults) and increases in anxiety and depression during the pandemic compared to previous timepoints; patterns of change appeared to be related to timing of lockdowns. This review provides important information on the impact of COVID-19 on the physical and mental health of individuals with eating disorders.

Objetivo: Un creciente conjunto de evidencia sugiere que las personas con trastornos de la conducta alimentaria (TCA) han experimentado síntomas de deterioro, mayor aislamiento y un aumento en los ingresos hospitalarios como resultado de la pandemia de COVID-19. A pesar de esto, no se han realizado revisiones sistemáticas que examinen la literatura revisada por pares de COVID-19 y TCA. Por lo tanto, esta revisión sistemática tuvo como objetivo sintetizar el impacto de la pandemia de COVID-19 en las personas con TCA.

Método: Las búsquedas en las bases de datos de la literatura revisada por pares se completaron en las bases de datos posteriores: CINAHL, Embase, MEDLINE y Psy-cINFO (de noviembre de 2019 al 20 de octubre de 2021). Se incluyeron todos los informes de investigación sobre la relación entre la pandemia de COVID-19 en individuos con TCA.

Resultados: Cincuenta y tres estudios cumplieron los criterios de inclusión, incluyendo 36,485 individuos con TCA. Los ingresos hospitalarios agrupados en los estudios demostraron en promedio un aumento del 48% (antes = 591, después = 876, n = 10 estudios) en los ingresos durante la pandemia en comparación con los puntos de tiempo previos a la pandemia. En esta revisión, el 36% de los estudios (n = 19) documentaron aumentos en los síntomas del trastorno alimentario durante la pandemia, este aumento en los síntomas del trastorno de la conducta alimentaria se documentó en pacientes con AN, TpA, BN y OSFED. Los estudios también demostraron aumentos en la ansiedad (n = 9) y la depresión (n = 8), sin embargo, los patrones de cambio parecían ser diagnósticos y específicos del momento (por ejemplo, encierros).

Discusión: Encontramos un gran aumento en el número de hospitalizaciones y un aumento en los síntomas de TCA, ansiedad, depresión y los cambios en el IMC en pacientes con TCA durante la pandemia. Sin embargo, estos cambios parecían ser diagnósticos y específicos del momento. Muchos estudios cualitativos describieron un deterioro en la sintomatología del trastorno de la conducta alimentaria (TCA) debido a la disminución del acceso a la atención y el tratamiento, los cambios en la rutina y la pérdida de estructura, la influencia negativa de los medios de comunicación y el aislamiento social. Se necesitan estudios futuros para centrarse en las poblaciones pediátricas, los nuevos diagnósticos de TCA y la gravedad de la enfermedad al momento de la presentación.

Palabras clave: trastornos de la conducta alimentaria, pandemia, COVID-19

The COVID-19 pandemic has resulted in significant health, economic, financial, and social consequences that have been implicated in the increased number of reported individuals with eating disorders (EDs). The various COVID-control measures (e.g., public health mandates such as lockdown measures and social restrictions) that have been implemented are thought to contribute to this increase in EDs . A recent survey found that the COVID-19 pandemic has impacted the general populations´eating behaviors (e.g., types of food consumption, uncontrolled eating, fewer structured meals), which have become increasingly disordered compared to before the pandemic (Ammar et al., 2020) . New onset problematic eating behaviors may arise in individuals as a result of public health mitigation strategies (e.g., lockdown orders, social distancing, and hand washing), increased physical activity at-home, and threats of food shortages, which may lead to hoarding (Weissman et al., 2020) . Experts in the field of EDs have suggested that the pandemic might have a negative impact on both the severity of symptoms and the rate of relapse in patients diagnosed with EDs Todisco & Donini, 2021; Touyz et al., 2020; Weissman et al., 2020) . In addition, the pandemic has resulted in unintended consequences for those with EDs including disruptions to regular routine (e.g., attending school and work), loss of perceived control (e.g., uncertainty about the future), increased social isolation from peers, emotional distress, and high levels of family distress and stress (Puhl et al., 2020; Schnepper et al., 2020) . Published studies have also shown that the pandemic has resulted in the deterioration of ED symptoms and an increase in ED-related hospitalizations (Graell et al., 2020; Papandreou et al., 2020) .

Abrupt closures and limited access to outpatient services, day treatment and inpatient treatment, and long wait lists have contributed to the emergence of unique challenges for people with EDs including uncovering patients with new EDs and recognizing those with exacerbation of ED symptoms and relapse (Richardson et al., 2020) . These challenges to the usual support networks and specialized ED services may have dire long-term consequences for affected individuals and their families (Richardson et al., 2020) .

Despite the growing body of evidence, no systematic reviews have been conducted on the impact of the COVID-19 pandemic on individuals with ED diagnoses across the lifespan, with regard to outcomes of hospitalizations, symptoms, and body mass index (BMI). The aims of this review were to: (1) systematically review all studies examining the impact of the COVID-19 pandemic on individuals with EDs including (a) severity of symptoms, (b) hospitalizations, and (c) BMI;

and (2) examine common themes across the qualitative studies. We hypothesized that individuals with EDs would have increases in both ED symptoms and psychiatric symptoms, increases in hospitalizations, and fluctuations in BMI during the COVID-19 pandemic compared to pre-pandemic time periods.

A systematic review is needed to enhance our understanding of the unique challenges for those vulnerable to developing EDs during the COVID-19 pandemic as well as those with pre-existing EDs. Furthermore, data from both quantitative and qualitative studies will aid in the understanding of the magnitude of the impact of the pandemic on the lives of individuals with EDs and their families. Results will help identify gaps in current research, contribute to the development of interventions to prevent or halt the deterioration of ED symptoms, inform hospital administrators and government policies, and help to prepare for future pandemics.

This review protocol was prospectively registered with the PROS-PERO database of systematic reviews (Registration Number: CRD42020219969). This systematic review was conducted in accordance with the meta-analysis of observational studies in epidemiology (MOOSE) guidelines and preferred reporting for systematic reviews and meta-analyses (PRISMA) (Liberati et al., 2009; Moher et al., 2015; Stroup et al., 2000) . Proquest, OpenGrey, SCOPUS, and Ethos. Furthermore, we searched the World Health Organization website, conducted a thorough Google Scholar, Google Search, and searched Clinicaltrials.gov for any relevant studies that would meet our inclusion criteria. After duplicate references were removed, two blinded reviewers independently screened titles and abstracts using the online Covidence systematic review software. Full-text articles were then independently reviewed by the same two blinded reviewers to determine inclusion in this systematic review in accordance with the selection criteria outlined below. The reference lists of any included articles were then individually searched for relevant studies not found through searching the online databases. The search strategies are provided in Table S1 .

Studies that met all of the following criteria were considered eligible for inclusion in this systematic review: (1) (3) used a study design that was either treatment based, qualitative, survey, cross-sectional, case series, or longitudinal; (4) articles written in any language; and (5) no exclusions due to age.

In addition, the following exclusion criteria were applied: (1) ineligible study design (review articles, opinion pieces, conference abstracts, and editorials without original data); and (2) due to the unique worldwide impact of the COVID-19 pandemic, reports utilizing data from other pandemics such as the 2002 severe acute respiratory syndrome (SARS) and 2012 Middle East respiratory syndrome (MERS) pandemics were not included.

For the systematic review, the following study characteristics were extracted: first author, year of publication, country, study design, sample size, outcomes reported, age (mean ± SD), sex/gender, socioeconomic status, race/ethnicity, types of EDs, hospitalization rates, symptom scores (mean ± SD), symptom scales, and key findings associated with EDs and the COVID-19 pandemic. For the descriptive results, the following data were extracted: (1) first author; (2) year of publication; (3) sample size; (4) changes in symptoms/BMI (mean ± SD); and (5) frequency / changes in hospitalizations.

Cross-sectional and longitudinal studies were assessed for quality using a modified Downs and Black instrument (Downs & Black, 1998) ; the modified checklist employs 14 items to appraise cross-sectional studies and 16 items for longitudinal studies, producing a total score up to 15 or 17 points, respectively, with higher scores representing greater quality. The modified Downs and Black instrument removes items related to the scoring of randomized control trials (e.g., randomization, allocation concealment).

Detailed descriptions of studies were provided in tabular format. For hospital admissions, we examined the average admissions prior to the pandemic compared to the average admission during the pandemic and reported the percent change. Initial agreement on title/abstract screening was assessed using the kappa statistic for interrater reliability between the reviewers. For qualitative studies and mixed methods studies, two independent reviewers compared and contrasted the results across 14 of the studies. The two reviewers reported on the themes within individual studies and created a list of common overlapping themes and subthemes across the studies. There was not an analysis of agreement between raters for the qualitative studies.

However, the raters worked closely together and there was no disagreement over the themes generated. In addition, the lead qualitative researcher closely supervised the analysis of the two raters.

Electronic database searches identified 1915 records; after duplicate references were removed, a total of 1212 abstracts and titles were screened. A total of 108 studies were retrieved and reviewed in full text. The level of agreement between the two reviewers for screening full text articles was high (κ = 0.87). Overall, 53 studies met the inclusion criteria and were included in this systematic review, see Figure 1 .

All peer-reviewed and gray literature studies included in this systematic review are described in detail in Table 1 . Only one study met our inclusion criteria from the gray literature search (Stoddard, 2021) , which was a graduate thesis. The majority of the included studies were published in 2021. There were 40 quantitative, 8 qualitative, and 6 mixed-methods studies. Twenty-nine studies were conducted in Europe (n = 10,234,580), 14 studies in North America (n = 5,204,295), 7 studies in Australia and New Zealand (n = 11,102), 3 studies in the Middle East (n = 104), and 1 study in South America (n = 32). In total, there were six treatments studies, with a total of 592 participants receiving treatment. An additional 1327 patients were receiving treatment before the COVID-19 pandemic, or throughout the pandemic period but were not included in a treatment study. Finally, there were 15 cross-sectional studies comparing separate groups before and after lockdown periods, and 15 longitudinal studies examining the same sample throughout the pandemic.

A total of 36,485 individuals with EDs were identified across all included studies (Table 1) Table S2 outlines the results of the modified Downs and Black instrument used to evaluate all studies in the systematic review. For crosssectional studies, the average Downs and Black score was 9.6/15 and for longitudinal studies the average score was 11.9/17, indicating predominantly poor quality across studies included in this review. The majority of studies included in this review clearly described main aims/objectives, measures utilized, and findings. However, most studies included in this review failed to mention the effects of possible confounders and adjust for important covariates in their analysis, for example, there was a lack of adjustment based on gender, age, and ED diagnoses.

Eleven studies compared the differences in admissions from before the pandemic to during the pandemic, the percent changes in admissions in individual studies varied from 0% to 123%, respectively (Ayton et al., 2021; Graell et al., 2020; Hansen et al., 2021; Haripersad et al., 2021; Jones et al., 2020; Lin et al., 2021; Matthews et al., 2021; Otto et al., 2021; Parsons et al., 2021; Spettigue et al., 2021; Springall et al., 2021) . The pooled hospital admissions across the studies demonstrated on average a 48% (pre = 591, post = 876, n = 10 studies) increase in ED admissions during the pandemic compared to previous timepoints. Notably, when examining the differences in pediatric admissions compared to adults, there was an average increase of 83% in pediatric admissions (n = 8 studies), whereas for adults there was an average increase of 16% in (1)

Annual household income: $0-10,000 per year: 9.1%

(1) $25,001-30,000: 9.1%

(1) $30,001-35,000: 9.1%

(1) $45,001-50,00: 9.1%

(1) $70,000-75,000: 9.1%

(1) >$100,000: 45.5% (5) Prefer not to answer: 9.1% (1) Giel (7) Job loss due to the pandemic: 7.5% (12) Other: 8.8% (14) Schlegl et al. admissions (n = 2 studies). Two studies did not have sufficient admission data and thus could not be included in the averages included above Matthews et al., 2021) , whereas three different cohort data points were extracted from Parsons et al. (2021) . BMI from baseline to pre-lockdown, but then a decrease in BMI while in-lockdown (Castellini et al., 2020) . Two of these studies found that there was no change in BMI. Many studies also demonstrated that individuals with EDs had increased anxiety (n = 9 studies) during the pandemic and depression (n = 8 studies).

In terms of lockdown measures, there were mixed results with some patients deteriorating and some improving during lockdown.

Several studies found worsening symptoms for ED patients during lockdown Brown et al., 2021; McCombie et al., 2020; , Nistico et al., 2021 Springall et al., 2021) and issues with accessing treatment services during lockdown (Akgül et al., 2021; Clark Bryan et al., 2020) . However, some studies demonstrated that patients did better during lockdown, for example, AN patients showed improvement of ED psychopathology and a progressive weight gain, and BN patients had less binge-eating episodes during lockdown (Castellini et al. 2020; Giel et al., 2021) , while other's found mixed results with some patients deteriorating and some improving during lockdown (Machado et al., 2020) . In terms of post-lockdown, some studies demonstrated improvement in ED symptoms (Akgül et al., 2021) , while others reported worsening symptoms post-lockdown, such as increases in binge eating (Giel et al., 2021) . Richardson et al., 2020; Rodríguez Guarin et al., 2021; Stewart et al., 2021; Stoddard, 2021; Termorshuizen et al., 2020; Vuillier et al., 2021; Zeiler et al., 2021) . Across these studies, individuals identified treatment as being shortened or delayed, or that they experienced barriers to seeking professional assistance (Branley-Bell & Talbot, 2020; Brown et al., 2021; Clark Bryan et al., 2020; Richardson et al., 2020; Rodríguez Guarin et al., 2021; Vuillier et al., 2021) . In a sample of 207 individuals with self-reported ED, Vuillier et al. (2021) identified 

The theme of isolation was mentioned by participants in seven studies (Branley-Bell & Talbot, 2020 , 2021 Brown et al., 2021; Hunter & Gibson, 2021; McCombie et al., 2020; Stoddard, 2021; Vuillier et al., 2021) ; feelings of loneliness, anxiety, and depression due to staying at home contributed to the worsening of ED symptoms.

Despite the overall negative impact of the COVID-19 pandemic on those with an ED, seven studies reported several positive outcomes (Branley-Bell & Talbot, 2020; Frayn et al., 2021; Hunter & Gibson, 2021; McCombie et al., 2020; Stoddard, 2021; Termorshuizen et al., 2020; Zeiler et al., 2021) . Throughout the pandemic, individuals cited that lockdown measures shielded them from previous stressors or triggers, allowed them to utilize free time for self-care, self-reflect, and some experienced an increase in social support (Branley-Bell & Talbot, 2020; Frayn et al., 2021; Hunter & Gibson, 2021; McCombie et al., 2020; Stoddard, 2021; Termorshuizen et al., 2020; Zeiler et al., 2021) .

To the best of our knowledge, this is the first systematic review to synthesize the impact of the COVID-19 pandemic on individuals with

EDs across the lifespan for both quantitative and qualitative studies.

Most notably, we found a positive effect in the increase in the number of hospitalizations due to EDs following the onset of the pandemic.

The pooled average across 11 studies showed a 48% increase in the number of hospital admissions during the pandemic compared to a similar time period the previous year, with an average increase of 83% and 16% in pediatric and adult admissions, respectively. This is likely an under-estimate; for example, one study only observed 2 months following the lockdown and showed a 0% change in hospital admissions compared to the same period the year prior (Graell et al., 2020) .

This brief follow-up period may not have allowed for sufficient time to capture the deterioration in ED symptoms. Other qualitative studies provided possible reasons for the significant increase in hospitalizations, including reduced access to health service and modified treatments shifting from in-person to virtual care (Branley-Bell & Talbot, 2020; Brown et al., 2021; Clark Bryan et al., 2020; Hunter & Gibson, 2021; McCombie et al., 2020; Richardson et al., 2020; Rodríguez Guarin et al., 2021; Stewart et al., 2021; Stoddard, 2021; Termorshuizen et al., 2020; Vuillier et al., 2021; Zeiler et al., 2021) .

These barriers and gaps in care, in addition to fear of contracting the virus, "coronophobia" (Haripersad et al., 2021) , may have contributed to delayed presentation for assessment, leading to further deterioration requiring admission to hospital for medical instability.

Some studies reported the impact of COVD-19 on different types of EDs, with variable outcomes. In one study, patients with AN and BN did not present with significant changes in weight and BMI , while patients BED and BN reported more frequent binge eating. (Termorshuizen et al., 2020.) . Similarly, Giel et al. (2021) found that participants with BED had a significant increase in BE episodes for 4 weeks during lockdown compared to before the COVID-19 outbreak, but less BE episodes compared to when initially entering the trial 3 years prior (Giel et al., 2021) . In addition, ED pathology for that same group was significantly higher during lockdown compared to when entering the trial and at the end of treatment, while self-reported BMI was lower (Giel et al., 2021) . In contrast, Machado et al. (2020) increased suicidal ideation, self-harm, and presentations to emergency and hospitalizations for the same (Hawton et al., 2021; Hill et al., 2021; Isumi et al., 2020; Leske et al., 2021; Thompson et al., 2021) .

Thus, there may be a compounding effect for patients with EDs as they have significantly greater psychiatric comorbidities with depression and anxiety compared to healthy controls (Godart et al., 2015; Milos et al., 2004) . This confirms the results from one study that found that more severe COVID-19-related posttraumatic symptoms were reported by patients with BN compared to healthy controls (Castellini et al., 2020) . Thus, it is not surprising that the added stress and uncertainty of the pandemic, in addition to loss of activities and social interactions may be exacerbating the mental health of this vulnerable group, triggering, or worsening an ED in some.

Many clinics moved to an online format to deliver treatment and meet the needs of many patients with EDs by utilizing eHealth treatments (e.g., video calls) and surveys to collect symptoms during the pandemic. Diagnostic and geographic variability was found in patients' response to virtual therapy. In one study, researchers examined patient satisfaction with telemedicine compared to face-to-face therapy and found that individuals with AN found telemedicine less acceptable compared to patients with OSFED (Fernandez-Aranda et al., 2020). Another study found geographic differences in video therapy uptake with higher utilization in patients with BN in the USA and Netherlands compared to individuals in Germany (Termorshuizen et al., 2020) . In qualitative studies many expressed satisfaction toward telehealth and remote therapy; however, some patients expressed issues with technical problems or that self-monitoring one's symptoms and weight was stressful (Frayn et al., 2021; Termorshuizen et al., 2020; Zeiler et al., 2021) . As virtual care will likely continue to play a role in patient care, more research is required to understand how to minimize barriers and optimize its use.

Out of the 53 studies included in this systematic review, only 10 studies were focused on pediatric populations. Therefore, it is unclear whether the results found in the review are generalizable to the pediatric population with EDs. However, Graell et al. (2020) found that almost half of the pediatric participants experienced worsening ED and emotional symptoms, and a quarter experienced self-harm and suicide risk (Graell et al., 2020) . In addition, other pediatric studies reported worsening eating behavior and worsening depression/ anxiety during the pandemic (Ünver et al., 2020; Zeiler et al., 2021) . In a case series of pediatric individuals, there was significant weight loss in all three patients included in the study (Ünver et al., 2020) . This may reflect a general trend in which the effects of the pandemic on mental health appear to have been more severe in young people (Bulloch et al., 2021) . This trend may have contributed to the higher pediatric admissions that we are seeing, as they had an average increase of 83% (n = 9 studies), whereas for adults there was an average increase of 16% in admissions (n = 2 studies).

There are several important limitations to consider when interpreting the results of our systematic review. The study designs included in this review had many heterogeneous features (e.g., the length of time under study for the analysis of hospital admissions) and thus aggregated statistics from a meta-analysis were not conducted as they would be difficult to interpret, this also led to the inability to statistically examine potential moderators that may contribute to heterogeneity in findings (e.g., ED diagnosis, country, age). According to our risk of bias assessment, the quality of studies included in our review was predominantly poor. The qualitative and mixed methods also had mixed samples when it comes to age and diagnosis, and many lacked standardized questionnaires to assess symptoms, rather drawing qualitative themes from interviews or survey responses. There was minimal pediatric data available. Thus, more pediatric data would help expand the COVID-19 ED research and may help researchers and clinicians understand the unique challenges that pediatric individuals with EDs experienced during the pandemic. Finally, there was also a lack of diversity in the samples of individual studies included in this review, for example, there was a clear lack of studies from specific regions around the world (e.g., Asia) that were strongly impacted by the pandemic, the majority of studies did not report the race or ethnicity of their participants and in the studies that did the majority of participants identified as being of European descent or White, there was a lack of data on sex/gender (e.g., samples were overwhelmingly female), and finally there was a lack of data on the socio-economic status of included participants with the majority of studies not reporting any data on socio-economic status or disparities. Thus, due to the lack of diversity in samples, this may impact the generalizability and representativeness of the study results and conclusions provided.

In conclusion, we found a large increase in the number of hospitalizations and an increase in ED symptoms, anxiety, depression, and changes to BMI in patients with EDs during the pandemic. However, these changes appeared to be age, diagnostic, and timing specific (e.g., better post-lockdown). Many qualitative studies described deterioration in ED symptomatology due to decreased access to care and treatment, changes to routine and loss of structure, negative influence of the media, and social isolation. Future studies are needed to focus on pediatric populations, new ED diagnoses, and severity of illness at presentation. 

The authors declare no conflicts of interest.

The effects of the COVID -19 lockdown on adolescents with an eating disorder and identifying factors predicting disordered eating behaviour

Effects of COVID-19 home confinement on eating behaviour and physical activity: Results of the ECLB-COVID19 International Online Survey

Risk, demand, capacity and outcomes in adult specialist eating disorder services in south-east of England before and since COVID-19

COVID-19 and eating disorders during confinement: Analysis of factors associated with resilience and aggravation of symptoms

Longitudinal change in adolescent depression and anxiety symptoms

Longitudinal experiences and impact of the COVID-19 pandemic among people with past or current eating disorders in Sweden

Exploring the impact of the COVID-19 pandemic and UKlockdown on individuals with experience of eating disorders

It is the only constant in what feels like a completely upside down and scary world": Living with an eating disorder during COVID-19 and the importance of perceived control for recovery and relapse

A qualitative exploration of the impact of COVID-19 on individuals with eating disorders in the UK

Poor mental health during the COVD-19 pandemic: Effect modification by age

The impact of COVID-19 epidemic on eating disorders: A longitudinal observation of pre versus post psychopathological features in a sample of patients with eating disorders and a group of healthy controls

Exploring the ways in which COVID -19 and lockdown has affected the lives of adult patients with anorexia nervosa and their carers

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

Psychological consequences and differential impact of the COVID-19 pandemic in patients with mental disorders

COVID-19 and implications for eating disorders

COVID isolation eating scale (CIES): Analysis of the impact of confinement in eating disorders and obesity-A collaborative international study

COVID-19 and binge eating: Patient perceptions of eating disorder symptoms, tele-therapy, and treatment implications

Eating behaviour and symptom trajectories in patients with a history of binge eating disorder during COVID-19 pandemic

Mood disorders in eating disorder patients: Prevalence and chronology of ONSET

Children and adolescents with eating disorders during COVID-19 confinement: Difficulties and future challenges

The impact of COVID-19 on eating disorder referrals and admissions in Waikato

Outbreak of anorexia nervosa admissions during the COVID-19 pandemic

Self-harm during the early period of the COVID-19 pandemic in England: Comparative trend analysis of hospital presentations

Suicide ideation and attempts in a pediatric emergency department before and during COVID-19

Narratives from within 'lockdown': A qualitative exploration of the impact of COVID-19 confinement on individuals with anorexia nervosa

Do suicide rates in children and adolescents change during school closure in Japan? The acute effect of the first wave of COVID-19 pandemic on child and adolescent mental health

Fewer respiratory admissions in COVID-19 era

College mental health before and during the COVID-19 pandemic: results from a nationwide survey

Eating disorders and trajectory of mental health across the COVID-19 pandemic: Results from the Understanding America study

How COVID-19 lockdown measures could impact patients with bulimia nervosa: Exploratory results from an ongoing experience sampling method study

Real-time suicide mortality data from police reports in Queensland, Australia, during the COVID-19 pandemic: an interrupted time-series analysis. The Lancet Psychiatry

Pilot outcomes from a multidisciplinary telehealth versus in-person intensive outpatient program for eating disorders during versus before the Covid-19 pandemic

The abrupt transition from face-to-face to online treatment for eating disorders: a pilot examination of patients' perspectives during the COVID-19 lockdown

Association of home quarantine and mental health among teenagers in wuhan, china, during the COVID-19 pandemic

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration

The impact of the COVID-19 pandemic on the number of adolescents/young adults seeking eating disorder-related care

Impact of COVID-19 lockdown measures on a cohort of eating disorders patients

Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study

Higher admission and rapid readmission rates among medically hospitalized youth with anorexia nervosa/atypical anorexia nervosa during COVID-19

Now It's Just Old Habits and Misery"-Understanding the impact of the Covid-19 pandemic on people with current or life-time eating disorders: A qualitative study

Suicide attempts and suicidal ideation: links with psychiatric comorbidity in eating disorder subjects

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

Risk and resilience factors for specific and general psychopathology worsening in people with eating disorders during COVID-19 pandemic: A retrospective Italian multicentre study

The impact of COVID-19 lockdown and of the following "re-opening" period on specific and general psychopathology in people with eating disorders: The emergent role of internalizing symptoms

The psychological impact of COVID-19-related lockdown measures among a sample of Italian patients with eating disorders: a preliminary longitudinal study. Eating and Weight Disorders -Studies on Anorexia

Medical admissions among adolescents with eating disorders during the COVID-19 pandemic

Comparing eating behaviours, and symptoms of depression and anxiety between Spain and Greece during the COVID -19 outbreak: Cross-sectional analysis of two different confinement strategies

Review of Ireland's first year of the COVID-19 pandemic impact on people affected by eating disorders: 'Behind Every Screen There Was A Family Supporting A Person With An Eating Disorder'

PRESS. Toronto, ON, Canada: Canadian Agency for Drugs and Technologies in Health

Eating and exercise behaviors in eating disorders and the general population during the COVID -19 pandemic in Australia: Initial results from the COLLATE project

Mental health of individuals with and without eating disorders across six months and two waves of COVID-19

Weight stigma as a predictor of distress and maladaptive eating behaviors during COVID-19: Longitudinal findings from the EAT study

Perceived impact of Covid-19 across different mental disorders: a study on disorder-specific symptoms, psychosocial stress and behavior

Positive outcomes from integrating telehealth into routine clinical practice for eating disorders during COVID-19

The impact of the COVID-19 pandemic on help-seeking behaviors in individuals suffering from eating disorders and their caregivers. General Hospital Psychiatry

Feasibility and acceptability of comprehensive virtual treatment in eating disorders: Perspectives from patients, parents and therapists during the COVID-19 pandemic (Viabilidad y Aceptabilidad del Tratamiento Integral Virtual en Trastornos Alimentarios: Perspectiva de Pacientes, Padres y Terapeutas Durante la Pandemia por COVID-19)

Eating disorders in times of the COVID-19 pandemic-Results from an online survey of patients with anorexia nervosa

Bulimia nervosa in times of the COVID-19 pandemic-results from an online survey of former inpatients

Being my own companion in times of social isolation -A 14-day mobile selfcompassion intervention improves stress levels and eating behavior

The impact of COVID-19 on adolescents with eating disorders: A cohort study

Impact of the coronavirus pandemic on anorexia nervosa and atypical anorexia nervosa presentations to an Australian tertiary paediatric hospital

Is this the 'new normal'? A mixed method investigation of young person, parent and clinician experience of online eating disorder treatment during the COVID-19 pandemic

Eating and body image disorders in the time of COVID19: An anthropological inquiry into the pandemic's effects on the bodies (Graduate theses and dissertations)

Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group

Incidence and outcomes of eating disorders during the COVID-19 pandemic

Early impact of COVID-19 on individuals with eating disorders: A survey of 1000 individuals in the United States and The Netherlands

Suicidal thoughts and behaviors in psychiatrically hospitalized adolescents pre-and post-COVID-19: A historical chart review and examination of contextual correlates

Eating disorders and obesity (ED&O) in the COVID-19 storm

Eating disorders in the time of COVID-19

COVID-19 pandemic-onset anorexia nervosa: Three adolescent cases

COVID-19 and eating disorder and mental health concerns in patients with eating disorders

The impact of the COVID-19 pandemic on individuals with eating disorders: The role of emotion regulation and exploration of online treatment experiences

Access to evidencebased care for eating disorders during the COVID-19 crisis

Impact of COVID-19 confinement on adolescent patients with anorexia nervosa: A qualitative interview study involving adolescents and parents

The impact of the COVID-19 pandemic on eating disorders: A systematic review

The data that support the findings of this study are available from the corresponding author upon reasonable request.

https://orcid.org/0000-0003-4931-0205Georgios Paslakis https://orcid.org/0000-0002-2069-0024